Excelyrate Capital

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 1
Average round size
info
The average size of a deal this fund participated in
$57M
Portfolio companies 1
Lead investments 0
Exits 1
Key employees Soon

Areas of investment

  • Biotechnology
  • Medical
  • Therapeutics
Summary

The usual cause for the fund is to invest in rounds with 7 partakers. The meaningful sponsors for the fund in investment in the same round are SunStates Fund, MPM Capital, Long March Investment Fund. In the next rounds fund is usually obtained by UTC Investment Co., UBS Oncology Impact Fund, Surveyor Capital.

Besides, a startup requires to be at the age of 1 and less years to receive the investment from the fund. Among the most popular fund investment industries, there are Medical, Biotechnology. Among the various public portfolio startups of the fund, we may underline Oncorus

The usual things for fund are deals in the range of 50 - 100 millions dollars. The important activity for fund was in 2016. The fund is constantly included in less than 2 investment rounds annually.

Read more

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Atwater Capital California, Los Angeles, United States
Colliers Proptech Accelerator Powered by Techstars Canada, Ontario, Toronto
CSI Starlight Company -
FAC Equities Boston, Massachusetts, United States
Founders Future France, Ile-de-France, Paris
Fred & Farid Digital Investment Fund New York, New York, United States
Goodman & Company, Investment Counsel Canada, Ontario, Toronto
GTR Ventures Central, Central Region, Singapore
KKR Real Estate Finance Trust New York, New York, United States
La Gajjar Group Ahmedabad, Gujarat, India
MedScience Ventures -
SHE AG -
SinoVest Capital -
Stanford Management Maine, Portland, United States
Swallow Point Ventures Pennsylvania, Pittsburgh, United States
Thin Line Capital California, Pasadena, United States
Torch Electron China, Fujian, Quanzhou
Valeo Créteil, France, Ile-de-France
Verance Capital -
Wandai Capital -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Oncorus

Biotechnology
Medical
Therapeutics
$57M19 Jul 2016 Cambridge, Massachusetts, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Excelyrate Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: